Skip to content

Safety of adenosine for intracranial aneurysm surgery

Assessment of safety and feasibility of adenosine-assisted clipping for unruptured intracranial aneurysm surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs061200023
Enrollment
10
Registered
2020-10-22
Start date
2020-12-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unruptured intracranial aneurysm

Interventions

Adenosine-induced hypotension during aneurysmal clipping Monitoring using electrocardiogram, arterial blood pressure, central venous presssure Standby transcutaneous pacing in preparation to temporary

Sponsors

HISHIKAWA Tomohito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20 years or older 2. Patients with written informed consent 3. Patients who are planned to receive clipping surgery for unruptured intracranial saccular aneurysm in our institute 4. Cases in which surgeon judged the decompression of aneurysm as effective in clipping

Exclusion criteria

Exclusion criteria: 1. coronary artery stenosis 2. Past history of ischemic heart disease 3. Aortic valve stenosis 4. Obstructive hypertrophic cardiomyopathy 5. Paroxysmal atrial fibrillation 6. Atrioventricular block 7. Bronchial asthma 8. Chronic obstructive pulmonary disease 9. 80 years or older 10. Pregnant woman, nursing woman 11. Patients who simultaneously receive clipping surgery for multiple aneurysms in one operation 12. Patients who were judged as no interest or having possibility of interruption of assessment of reserach by research responsible physician

Design outcomes

Primary

MeasureTime frame
modified Rankin Scale (mRS) at 30 days after surgery

Secondary

MeasureTime frame
1. Completeness of clipping 2. Total doses of adenosine 3. Duration between adenosine administration and clipping 4. mRS at discharge and at 90 days after surgery 5. Prevalence and duration of hypotension by adenosine administration 6. Adverse events caused by adenosine administration 7. Other adverse events

Contacts

Public ContactTomohito HISHIKAWA

Okayama University Hospital

t-hishi@md.okayama-u.ac.jp+81-86-235-7336

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026